Community/Retail

Innovative digital twin technology revolutionizes brain cancer treatment by predicting tumor metabolism and personalizing therapies for better patient outcomes.

High out-of-pocket costs lead patients to skip medications. Financial assistance programs improve adherence, but complex insurance strategies may hinder access.

The glucagon-like peptide-1 (GLP-1) receptor agonist medications evaluated included semaglutide, tirzepatide, and liraglutide.

Nina Masters, PhD, MPH, explains how early adherence to pediatric vaccines strongly predicts timely measles, mumps, and rubella (MMR) vaccination.

Food insecurity and social instability significantly increase long COVID risk in children, highlighting the need for targeted public health interventions.

Hawaii has secured a $700 million settlement with the manufacturers of Plavix following a lawsuit alleging they concealed for years the drug's ineffectiveness and potential danger for individuals of East Asian or Pacific Islander descent, a risk that the FDA later required to be disclosed with a boxed warning.

A tour through GLP-1’s unexpected biology.

Polypharmacy poses significant risks for patients, highlighting the need for comprehensive medication reviews and patient involvement.

According to the news release, the manufacturers have 30 days to respond.

Explore the differences between oral and injectable semaglutide for weight management, focusing on adherence, adverse effects, and patient preferences.

AbbVie partners with the Trump administration to enhance drug affordability and access, committing to significant investments in US pharmaceutical innovation.

Recombinant zoster vaccination against shingles was found to significantly reduce the risk of heart disease and dementia, even after a prior case of shingles.

New research reveals a gut bacteria-derived molecule that enhances lung cancer immunotherapy, potentially improving outcomes for patients with limited treatment options.

Pharmacists enhancing patient care through medication optimization, screenings, and interprofessional collaboration.

Jeffery A. Goad, PharmD, MPH, explains how the shift toward shared clinical decision-making for pediatric vaccines may complicate counseling, reduce vaccine uptake, and increase public health risks.

Pitavastatin shows promise as a novel treatment for triple-negative breast cancer, enhancing chemotherapy efficacy and targeting cancer cell survival pathways.

Dave Berkus’s quip might define the most significant transition in buying and selling medications since the inception of pharmacy benefit managers.

The findings reemphasize a need for mental health support for those in the pharmacy profession.

Pharmacists play a vital role in mental health care, enhancing treatment continuity and bridging gaps between mental and physical health for patients with serious mental illness.

Recently released guidelines enhance chronic kidney disease management, emphasizing early detection and innovative treatments for better patient outcomes.

The FDA approves Naox Link, a groundbreaking in-ear EEG device, transforming brain monitoring and enhancing neurologic care for patients and pharmacists.

Long-term type 2 diabetes significantly increases cardiovascular disease risk, revealing potential biomarkers for early intervention and prevention strategies.

The pivotal clinical trial supports the concomitant administration of tirzepatide and ixekizumab, which significantly improves outcomes for patients with psoriatic arthritis (PsA) and obesity.

Recent studies reveal that weight recovery in anorexia nervosa does not ensure muscle restoration, highlighting the need for comprehensive recovery strategies.

Study author Nina B. Masters, PhD, MPH, highlighted an increase since the pandemic in the rates of patients missing their dose of measles, mumps, and rubella (MMR) vaccination at age 2 years.

Study authors describe a framework to help patients with chronic kidney disease (CKD) change and adhere to diets.

Collaborative health care efforts are needed to effectively manage asthma, and pharmacists play a key role in optimizing asthma treatment plans.

Jeffery A. Goad, PharmD, MPH, explains how recent HHS policy changes reorganizing the childhood immunization schedule could complicate routine vaccination practices and increase the risk of gaps in pediatric disease prevention.